 |
Recombinant human antithrombin III |
|---|---|
| Trade Name | |
| Orphan Indication | Antithrombin III dependent heparin resistance requiring anticoagulation |
| USA Market Approval | USA |
| USA Designation Date | 2000-04-06 00:00:00 |
| Sponsor | AT III LLC;c/o Genzyme Corporation, 15 Pleasant St. Connector, P.O. Box 9322;Framingham, Massachusetts, 01701 |
